DB14834Investigational
Olendalizumab is under investigation in clinical trial NCT01883544 (Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects).
- Mechanism
- Curator reviewed
Pharmacologically active on Complement C5
- Code names
- ALXN1007
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Olendalizumab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account